期刊文献+

胆汁酸与非酒精性脂肪性肝病的关系 被引量:1

Association between bile acids and nonalcoholic fatty liver disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)患病率的迅速增加亟需新的治疗方法来预防疾病进展为肝纤维化、肝硬化及肝癌。尽管已经为阐明NAFLD疾病进展的病理机制做出了不懈努力,但目前尚无有效的治疗方法。胆汁酸(BA)通过激活核受体和G蛋白偶联受体调控全身代谢,已被确定为参与脂质、葡萄糖和能量代谢的重要信号分子。BA稳态的失调与NAFLD疾病的严重程度有关。本文总结了BA代谢中的重要配体和其在NAFLD进展中的作用,以期为靶向BA信使治疗NAFLD提供依据。 With the rapid increase in the prevalence rate of nonalcoholic fatty liver disease(NAFLD),new treatment methods are needed to prevent disease progression to liver fibrosis,liver cirrhosis,and liver cancer.Although great efforts have been made to clarify the pathological mechanisms of NAFLD disease progression,there are still no effective treatment methods at present.Bile acids(BAs)regulate systemic metabolism by activating nuclear receptors and G protein-coupled receptors and have been identified as important signaling molecules involved in lipid,glucose,and energy metabolism.Dysregulation of BA homeostasis is associated with the severity of NAFLD.This article summarizes the important ligands in BA metabolism and their role in the progression of NAFLD,in order to provide a basis for the treatment of NAFLD by targeting BA messengers.
作者 王俊俊 蔡晓波 陆伦根 WANG Junjun;CAI Xiaobo;LU Lungen(Department of Gastroenterology,Shanghai General Hospital,Shanghai Jiao Tong University,Shanghai 200080,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2023年第5期1166-1171,共6页 Journal of Clinical Hepatology
基金 国家自然科学基金(81970528)。
关键词 非酒精性脂肪性肝病 胆汁酸类和盐类 G蛋白偶联受体 法尼醇X受体 Non-alcoholic Fatty Liver Disease Bile Acids and Salts Receptors,G-Protein-Coupled Farnesoid X Receptor
  • 相关文献

参考文献2

二级参考文献48

  • 1Nobili V, Alkhouri N, Alisi A, Della Corte C, Fitzpatrick E, RaponiM, Dhawan A. Nonalcoholic fatty liver disease: a challenge for pediatricians. JAMA Pediatr 2015; 169: 170-176 [PMID: 25506780DOI: 10.1001/jamapediatrics.2014.2702].
  • 2Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, ContrerasM, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liverdisease and nonalcoholic steatohepatitis among a largely middleagedpopulation utilizing ultrasound and liver biopsy: a prospectivestudy. Gastroenterology 2011; 140: 124-131 [PMID: 20858492DOI: 10.1053/j.gastro.2010.09.038].
  • 3Anstee QM, Targher G, Day CP. Progression of NAFLD todiabetes mellitus, cardiovascular disease or cirrhosis. Nat RevGastroenterol Hepatol 2013; 10: 330-344 [PMID: 23507799 DOI:10.1038/nrgastro.2013.41].
  • 4Vernon G, Baranova A, Younossi ZM. Systematic review: theepidemiology and natural history of non-alcoholic fatty liver diseaseand non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x].
  • 5Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histologyin obese patients undergoing bariatric surgery. J Hepatol 2006; 45:600-606 [PMID: 16899321].
  • 6Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E,Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and itsconnection with insulin resistance, dyslipidemia, atherosclerosisand coronary heart disease. Nutrients 2013; 5: 1544-1560 [PMID:23666091 DOI: 10.3390/nu5051544].
  • 7Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA,Younossi ZM, Ahmed A. Nonalcoholic steatohepatitis is the secondleading etiology of liver disease among adults awaiting livertransplantation in the United States. Gastroenterology 2015; 148:547-555 [PMID: 25461851 DOI: 10.1053/j.gastro.2014.11.039].
  • 8Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, HuiJM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, WeltmanM, George J. NASH and insulin resistance: Insulin hypersecretionand specific association with the insulin resistance syndrome.Hepatology 2002; 35: 373-379 [PMID: 11826411].
  • 9Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A,Erbel R, Blankstein R, Feldman T, Al-Mallah MH, Santos RD,Budoff MJ, Nasir K. A systematic review: burden and severity ofsubclinical cardiovascular disease among those with nonalcoholicfatty liver; should we care- Atherosclerosis 2013; 230: 258-267[PMID: 24075754 DOI: 10.1016/j.atherosclerosis.2013.07.052].
  • 10Than NN, Newsome PN. A concise review of non-alcoholicfatty liver disease. Atherosclerosis 2015; 239: 192-202 [PMID:25617860 DOI: 10.1016/j.atherosclerosis.2015.01.001].

共引文献330

同被引文献23

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部